ReviewBMJ open2014

Recombinant human activated protein C for the treatment of severe sepsis and septic shock: a study protocol for incorporating observational evidence using a Bayesian approach.

Zhongheng ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.